November 5, 2012

The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

November 5, 2012

Pharmacy automation manufacturer Kirby Lester has launched a version of one of its tablet counters with streamlined verification software.

November 5, 2012

Improving medication adherence in specialty pharmacy could be equivalent to introducing a new blockbuster drug. That’s how Diplomat Specialty Pharmacy president and CEO Phil Hagerman put it at Drug Store News’ Specialty Pharmacy Roundtable two years ago. 


November 5, 2012

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis.

November 2, 2012

Given the extent of the meningitis outbreak linked to a compounding pharmacy in Massachusetts, new regulations for such pharmacies might be a good idea, but how to implement them remains uncertain.

(THE NEWS: Meningitis outbreak linked to compounding pharmacy spawns new proposed legislation. Click here to read the story.)

November 2, 2012

Rep. Edward Markey, D-Mass., on Thursday announced plans to introduce legislation that would strengthen federal regulations of compounding pharmacies.

November 1, 2012

Some generic drugs may come under more scrutiny from the Food and Drug Administration amid reports that the generic version of a treatment for depression didn't work as well as the branded version, according to published reports.

November 1, 2012

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

October 31, 2012

Energy-X, a division of Pacific Shore Holdings, has introduced The Juice — the first neutral-tasting energy supplement mixer that consumers can add to juice, sports drinks, water and more.

October 31, 2012

Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.

October 31, 2012

Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.

October 29, 2012

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

October 29, 2012

As Hurricane Sandy makes landfall today, CVS/pharmacy has announced that, while complying with any mandatory evacuation orders given by local officials, it is keeping its stores in affected areas open for as long as possible. CVS is also deploying generators throughout affected markets as needed to provide power to key store locations in the event of power outages.

October 29, 2012

Par Pharmaceutical Cos. has bought rights to a generic version of a drug used to treat bipolar disorder and schizophrenia.

October 29, 2012

Rite Aid is stocking extra emergency supplies and keeping its pharmacies open as Hurricane Sandy bears down on the East Coast, the retail pharmacy chain said.

October 29, 2012

About 97% of online pharmacies are "rogue" operations operating outside U.S. laws and regulations, according to a new report.

October 29, 2012

As officials across the East Coast closely monitor the approach of Hurricane Sandy, Walgreens and Duane Reade on Saturday offered several preparation tips to ensure uninterrupted access to prescription medications.

October 29, 2012

The Food and Drug Administration has approved a Type 2 diabetes drug made by Watson Pharmaceuticals, the company said, following a federal court's order for the agency to approve the drug.

October 26, 2012

The Food and Drug Administration said it found a number of problems with cleanliness at a compounding pharmacy linked to a meningitis outbreak that has so far sickened hundreds of people and killed two dozen in a report released Friday.

October 26, 2012

Progress at re-opening its manufacturing facility in Lincoln, Neb., has been slow-going, Novartis reported Thursday, but the company has contracted third-party manufacturers to resume production of Excedrin, Lamisil and Triaminic.

October 26, 2012

As many as 97% of parents are confident they administered the correct dose of acetaminophen to their sick child when using AccuDial Pharmaceutical's weight-based dosing label, according to research published earlier this year.

October 25, 2012

The Food and Drug Administration has approved a generic drug for leukemia made by a subsidiary of Par Pharmaceutical Cos.

October 25, 2012

The Food and Drug Administration has declined to approve a drug developed by United Therapeutics Corp. for treating a potentially lethal high blood pressure condition.

October 25, 2012

The National Association of Chain Drug Stores Foundation on Thursday applauded a report illustrating the impact medication adherence can and should have on reducing hospital readmission rates, and the critical role community pharmacists play in coordinated care approaches to enhancing patient medication adherence.